Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

CRHXX vs. MFEKX: which is better?

Bottom line

CRHXX vs MFEKX: the short answer

CRHXX (MFS U.S. Government Cash Reserve Fund) and MFEKX (MFS Growth Fund) are both money market funds.

CRHXX is cheaper at 0.45% vs 0.52% — a difference of $7.00 a year per $10,000 invested.

Over five years, MFEKX returned +11.5% a year vs +2.1% for CRHXX (reporting dates differ).

Updated Nov 19, 2026

CRHXX vs MFEKX side by side

CRHXXMFEKX
TypeMoney market fundMutual fund
Fund familyMFSMFS
CategoryMoney MarketLarge Growth
Expense ratio0.45%0.52%
Annual cost per $10k$45$52
10-yr cost on $10k (prospectus)$713$664
Max front load0%0%
12b-1 fee0%0%
1-yr return+4.9%+12.4%
5-yr return (annualized)+2.1%+11.5%
10-yr return (annualized)+1.4%+15.7%
Best quarter——
Worst quarter——
Net assets (fund)—$41.6B
Number of holdings—70
Portfolio turnover—36%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

CRHXX and MFEKX share none of their top holdings.

CRHXX top 10

    MFEKX top 10

    1. NVIDIA Corp. — 15.28%
    2. Apple, Inc. — 9.50%
    3. Alphabet, Inc. — 9.33%
    4. Microsoft Corp. — 7.53%
    5. Amazon.com, Inc. — 7.33%
    6. Broadcom, Inc. — 4.64%
    7. Mastercard, Inc. — 2.78%
    8. GE Vernova, Inc. — 2.35%
    9. Meta Platforms, Inc. — 2.25%
    10. Seagate Technology Holdings plc — 1.83%

    FAQ

    What is the difference between CRHXX and MFEKX?
    CRHXX (MFS U.S. Government Cash Reserve Fund) and MFEKX (MFS Growth Fund) are both money market funds. CRHXX is cheaper at 0.45% vs 0.52% — a difference of $7.00 a year per $10,000 invested.
    Which is cheaper, CRHXX or MFEKX?
    CRHXX has the lower expense ratio (0.45%).
    Should I own both CRHXX and MFEKX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.